We conducted a genetic screen of ATM in the Australian Breast Cancer Family Registry (ABCFR), an Australian population-based case–control–family study of breast cancer, with the purpose of estimating the prevalence and penetrance of ATM pathogenic variants in this cohort. This evidence concerns the gene ATM and breast cancer.